EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?

Marta Waliszewska-Prosół, Paolo Martelletti

Pharmacotherapy in Psychiatry and Neurology · 2026

DOI: 10.17219/fpn/241877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Marta Waliszewska-Prosół und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Waliszewska-Prosół, M., & Martelletti, P. (2026). GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/241877

Vancouver

Waliszewska-Prosół M, Martelletti P. GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/241877

BibTeX
@article{WaliszewskaPros2026,
  author = {Waliszewska-Prosół, Marta and Martelletti, Paolo},
  title = {GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?},
  journal = {Pharmacotherapy in Psychiatry and Neurology},
  year = {2026},
  doi = {10.17219/fpn/241877}
}
Kostenlos starten →